Volume 21 Number 4
30 April 2019

Home > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 4, 30 April


Kim MM, Speers C, Li P, Schipper M, Junck L, Leung D, Orringer D, Heth J, Umemura Y, Spratt DE, Wahl DR, Cao Y, Lawrence TS, Tsien CI.
Dose-intensified chemoradiation is associated with altered patterns of failure and favorable survival in patients with newly diagnosed glioblastoma.
J Neurooncol. 2019 Apr 11, 2019;143(2):313-319. doi: 10.1007/s11060-019-03166-3. PMID: 30977058 Observational study. ˍ

Chapman CH, Hara JH, Molinaro AM, Clarke JL, Oberheim Bush NA, Taylor JW, Butowski NA, Chang SM, Fogh SE, Sneed PK, Nakamura JL, Raleigh DR, Braunstein SE.
Reirradiation of recurrent high-grade glioma and development of prognostic scores for progression and survival.
Neurooncol Pract. 2019 Apr 12, 2019;6(5):364-374. doi: 10.1093/nop/npz017. PMID: 31555451. Observational study. ˍ

Zaazoue MA, Manley PE, Kapur K, Ullrich NJ, Silvera VM, Goumnerova LC.
Natural History and Management of Incidentally Discovered Focal Brain Lesions Indeterminate for Tumor in Children.
Neurosurgery. 2019 Apr 15, 2020;86(3):357-365. doi: 10.1093/neuros/nyz078. PMID: 30989228. Observational study. ˍ

Forte IM, Indovina P, Iannuzzi CA, Cirillo D, Di Marzo D, Barone D, Capone F, Pentimalli F, Giordano A.
Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.
Int J Oncol. 2019 Apr 16, 2019;54(6):2189-2199. doi: 10.3892/ijo.2019.4788. PMID: 31081046. Laboratory investigation. ˍ

Neuhauser M, Roetzer T, Oberndorfer S, Kitzwoegerer M, Payer F, Unterluggauer JJ, Haybaeck J, Stockhammer G, Iglseder S, Moser P, Thomé C, Stultschnig M, Wuertz F, Brandner-Kokalj T, Weis S, Bandke D, Pichler J, Hutterer M, Krenosz KJ, Boehm A, Mayrbaeurl B, Hager-Seifert A, Kaufmann H, Dumser M, Reiner-Concin A, Hoenigschnabl S, Kleindienst W, Hoffermann M, Dieckmann K, Kiesel B, Widhalm G, Marosi C, Jaeger U, Hainfellner A, Hackl M, Hainfellner JA, Preusser M, Woehrer A.
Increasing use of immunotherapy and prolonged survival among younger patients with primary CNS lymphoma: a population-based study.
Acta Oncol. 2019 Apr 17, 2019;58(7):967-976. doi: 10.1080/0284186X.2019.1599137. PMID: 30994047. Observational study. ˍ

Jin MC, Wu A, Xiang M, Azad TD, Soltys SG, Li G, Pollom EL.
Prognostic Factors and Treatment Patterns in the Management of Giant Cell Glioblastoma.
World Neurosurg. 2019 Apr 19, 2019;128:e217-e224. doi: 10.1016/j.wneu.2019.04.103. PMID: 31009783. Observational study. ˍ

Tzaridis T, Gepfner-Tuma I, Hirsch S, Skardelly M, Bender B, Paulsen F, Schaub C, Weller J, Schäfer N, Herrlinger U, Tabatabai G.
Regorafenib in advanced high-grade glioma: a retrospective bicentric analysis.
Neuro Oncol. 2019 Apr 23, 2019;21(7):954-955. doi: 10.1093/neuonc/noz071. PMID: 31089718. Observational study. ˍ

Miki K, Yoshimoto K, Yamada Y, Kabashima A, Kuga D, Oda Y, Iihara K.
Rapid growth of metastatic brain tumor from gastric undifferentiated pleomorphic sarcoma: A case report.
Surg Neurol Int. 2019 Apr 24, 2019;10:74. doi: 10.25259/SNI-84-2019. PMID: 31528412. Case report. ˍ

Tamai S, Kinoshita M, Sabit H, Furuta T, Miyashita K, Yoshimura K, Homma T, Harada K, Nakada M.
Case of metastatic glioblastoma with primitive neuronal component to the lung.
Neuropathology. 2019 Apr 25, 2019;39(3):218-223. doi: 10.1111/neup.12553. PMID: 31025405. Case report. ˍ

Katsigiannis S, Krischek B, Barleanu S, Grau S, Galldiks N, Timmer M, Kabbasch C, Goldbrunner R, Stavrinou P.
Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma.
Radiat Oncol. 2019 Apr 29, 2019;14(1):73. doi: 10.1186/s13014-019-1272-6. PMID: 31036031. Observational study. ˍ